Evidence map›Paper›PMID 35334801›Full record

ArticleNutrients2022

Neuroprotective Effect of 3',4'-Dihydroxyphenylglycol in Type-1-like Diabetic Rats-Influence of the Hydroxytyrosol/3',4'-dihydroxyphenylglycol Ratio.

María Dolores Rodríguez-Pérez, Inmaculada Pérez de Algaba, Esther Martín-Aurioles, María Monsalud Arrebola, Laura Ortega-Hombrados, Cristina Verdugo, María África Fernández-Prior, Alejandra Bermúdez-Oria, José Pedro De La Cruz, José Antonio González-Correa

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Extra Virgin Olive Oil and Metabolic Diseases.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

María Dolores Rodríguez-PérezDepartment of Pharmacology, Biomedical Research Institute (IBIMA), School of Medicine, University of Málaga, 29010 Málaga, Spain.ORCID 0000-0002-8722-4378
Inmaculada Pérez de AlgabaClinical Laboratory Department, Public Hospital, Montilla, 14550 Córdoba, Spain.
Esther Martín-AuriolesUGC La Roca, District Sanitary of Málaga-Guadalhorce, 29001 Málaga, Spain.
María Monsalud ArrebolaUGC Clínical Laboratory, Hospital Axarquía, AGSEMA, 29740 Málaga, Spain.ORCID 0000-0002-4843-0718
Laura Ortega-HombradosDepartment of Pharmacology, Biomedical Research Institute (IBIMA), School of Medicine, University of Málaga, 29010 Málaga, Spain.
Cristina VerdugoDepartment of Pharmacology, Biomedical Research Institute (IBIMA), School of Medicine, University of Málaga, 29010 Málaga, Spain.
María África Fernández-PriorInstituto de la Grasa, Consejo Superior de Investigaciones Científicas (CSIC), Ctra. Utrera Km 1, Campus Universitario Pablo de Olavide, Edificio 46, 41013 Seville, Spain.ORCID 0000-0002-8292-3081
Alejandra Bermúdez-OriaInstituto de la Grasa, Consejo Superior de Investigaciones Científicas (CSIC), Ctra. Utrera Km 1, Campus Universitario Pablo de Olavide, Edificio 46, 41013 Seville, Spain.ORCID 0000-0002-3632-3595
José Pedro De La CruzDepartment of Pharmacology, Biomedical Research Institute (IBIMA), School of Medicine, University of Málaga, 29010 Málaga, Spain.ORCID 0000-0002-9613-6660
José Antonio González-CorreaDepartment of Pharmacology, Biomedical Research Institute (IBIMA), School of Medicine, University of Málaga, 29010 Málaga, Spain.ORCID 0000-0001-8862-3760
Instituto de Investigación Biomédica de Málaga · ESConsejo Superior de Investigaciones Científicas · ES

Funding

Consejería de Salud. Junta de Andalucía (Spain), Proyectos de Investigación en Salud [Regional Ministry of Health. Junta de Andalucía (Spain), Health Research Projects] PI-0129-2017
6 · The paper itself

Abstract

The aim of this study was to assess the possible neuroprotective effect of 3',4'-dihydroxyphenylglycol (DHPG), a polyphenol from extra virgin olive oil (EVOO), in an experimental model of diabetes and whether this effect is modified by the presence of another EVOO polyphenol, hydroxytyrosol (HT). The neuroprotective effect was assessed in a hypoxia-reoxygenation model in brain slices and by quantifying retinal nerve cells. The animals were distributed as follows: (1) normoglycemic rats (NDR), (2) diabetic rats (DR), (3) DR treated with HT (5 mg/kg/day p.o.), (4) DR treated with DHPG (0.5 mg/kg/day), or (5) with 1 mg/kg/day, (6) DR treated with HT plus DHPG 0.5 mg/kg/day, or (7) HT plus 1 mg/kg/day p.o. DHPG. Diabetic animals presented higher levels of oxidative stress variables and lower numbers of neuronal cells in retinal tissue. The administration of DHPG or HT reduced most of the oxidative stress variables and brain lactate dehydrogenase efflux (LDH) as an indirect index of cellular death and also reduced the loss of retinal cells. The association of DHPG+HT in the same proportions, as found in EVOO, improved the neuroprotective and antioxidant effects of both polyphenols.

Indexed as

Diabetes Mellitus, ExperimentalNeuroprotective AgentsPhenylethyl AlcoholAnimalsRatsRats, Wistar3,4-dihydroxyphenylethanolNeuroprotective AgentsPhenylethyl Alcohol3′,4′-dihydroxyphenylglycoldiabetes mellitusdiabetic neuropathyextra virgin olive oilhydroxytyrosol

Identifiers

PMID35334801
PMCPMC8950825
OpenAlexW4220873340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.